Equity Details
Price & Market Data
Price: $6.81
Daily Change: -$0.09 / 1.32%
Daily Range: $6.77 - $7.17
Market Cap: $47,894,764
Daily Volume: 32,159
Performance Metrics
1 Week: -36.53%
1 Month: 14.26%
3 Months: -23.65%
6 Months: -63.80%
1 Year: 66.10%
YTD: -44.18%
About Scilex Holding Company (SCLX)
Detailed report on Scilex Holding Company (SCLX). Current price: 6.81, daily change: -$0.09 / 1.32%. Market cap: 47,894,764. Explore all performance metrics.
Company Details
Employees: 34
Sector: Health technology
Industry: Pharmaceuticals: other
Country: United States
Details
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. The company also develops three product candidates, including SP-102 (10 mg, dexamethasone sodium phosphate viscous gel - SEMDEXA), a novel viscous gel formulation of a used corticosteroid for epidural injections, which has completed a phase 3 study to treat lumbosacral radicular pain or sciatica; SP-103 (lidocaine topical system) 5.4%, a formulation of ZTlido for the treatment of chronic neck pain and low back pain (LBP) that has completed a phase 2 trial; and SP-104 (4.5 mg low-dose naltrexone hydrochloride delayed-release capsules), a novel low-dose delayed-release naltrexone hydrochloride, which has completed phase 1 trials for the treatment of fibromyalgia. It has an agreement with Oishi and Itochu to develop lidocaine tape products, including ZTlido and SP-103; and Lifecore Biomedical, LLC for clinical trial material manufacturing and development services for SEMDEXA. Scilex Holding Company is based in Palo Alto, California.